Bio Path News - BPTH

Company Name	Stock Ticker Symbol	Market	Type
Bio Path Holdings Inc	BPTH	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.04	-1.61%	2.45	08:34:55

Open Price	Low Price	High Price	Close Price	Prev Close
				2.49

more quote information »

Recent News

Date	Time	Source	Heading
4/19/2024	12:14	GLOBE	Bio-Path Holdings, Inc. Announces Closing of $1.2 Million..
4/18/2024	13:57	GLOBE	Bio-Path Holdings, Inc. Announces $1.2 Million Registered..
4/18/2024	07:00	GLOBE	Bio-Path Holdings Announces Successful Completion of Higher..
4/15/2024	07:00	GLOBE	Bio-Path Holdings Expands Global Patent Portfolio
4/02/2024	07:00	GLOBE	Bio-Path Holdings Provides 2024 Clinical and Operational..
3/11/2024	07:00	EDGAR2	Form 8-K - Current report
3/08/2024	17:11	EDGAR2	Form S-1 - General form for registration of securities under..
3/08/2024	07:10	EDGAR2	Form 8-K - Current report
3/08/2024	07:00	GLOBE	Bio-Path Holdings Reports Full Year 2023 Financial Results
3/08/2024	06:22	IHMARKETNEWS	U.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil..
3/07/2024	16:21	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/2024	07:00	GLOBE	Bio-Path Holdings to Announce Fourth Quarter and Full Year..
2/29/2024	06:00	EDGAR2	Form RW - Registration Withdrawal Request
2/23/2024	07:01	EDGAR2	Form 8-K - Current report
2/21/2024	07:00	GLOBE	Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
2/02/2024	16:39	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/02/2024	16:10	EDGAR2	Form 8-K - Current report
1/23/2024	17:20	EDGAR2	Form 8-K - Current report
1/23/2024	16:51	EDGAR2	Form S-1/A - General form for registration of securities..
1/17/2024	16:52	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/10/2024	16:10	EDGAR2	Form 8-K - Current report
1/10/2024	07:00	GLOBE	Bio-Path Holdings Announces Completion of First Dose Cohort..
1/04/2024	17:18	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/22/2023	16:06	EDGAR2	Form PRE 14A - Other preliminary proxy statements
12/22/2023	16:05	EDGAR2	Form S-1 - General form for registration of securities under..
12/15/2023	16:05	EDGAR2	Form 8-K - Current report
12/14/2023	16:05	EDGAR2	Form 8-K - Current report
12/14/2023	07:00	GLOBE	Bio-Path Holdings Successfully Completes First Dose Cohort..
12/08/2023	16:05	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/08/2023	16:05	EDGAR2	Form 8-K - Current report
11/15/2023	07:30	EDGAR2	Form 8-K - Current report
11/15/2023	07:00	GLOBE	Bio-Path Holdings Reports Third Quarter 2023 Financial..
11/08/2023	07:00	GLOBE	Bio-Path Holdings to Announce Third Quarter 2023 Financial..
10/27/2023	16:35	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
10/27/2023	16:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
10/24/2023	16:30	EDGAR2	Form 8-K - Current report
10/24/2023	07:00	GLOBE	Bio-Path Holdings to Host Virtual Key Opinion Leader Event..
9/15/2023	16:30	EDGAR2	Form 8-K - Current report
9/08/2023	16:01	GLOBE	Bio-Path Holdings to Present at H.C. Wainwright 25th Annual..
8/15/2023	07:10	EDGAR2	Form 8-K - Current report
8/15/2023	07:00	GLOBE	Bio-Path Holdings Reports Second Quarter 2023 Financial..
8/14/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	07:00	GLOBE	Bio-Path Holdings to Announce Second Quarter 2023 Financial..
8/07/2023	16:42	EDGAR2	Form 8-K - Current report
8/07/2023	07:21	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/07/2023	07:16	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
8/03/2023	08:22	GLOBE	Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million..
8/03/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/01/2023	17:02	EDGAR2	Form 8-K - Current report
8/01/2023	16:05	EDGAR2	Form S-1/A - General form for registration of securities..